Search

  • Home
  • Recent Issues
  • Articles by Topic
  • Conferences
    • The MedTech Strategist Innovation Summit DUBLIN 2018 – Apr. 17-19
    • The MedTech Strategist Innovation Summit San Francisco 2017 – Nov. 28-29
    • The Medical Alley Innovation Summit Minneapolis 2017 – Sept. 18-19
    • The MedTech Strategist Innovation Summit DUBLIN 2017 – Apr. 25-27
    • Emerging Medical Technologies (EMT) Summit – Nov. 9-11, 2016
    • Innovation In Medtech DUBLIN – April 12-14, 2016
    • Emerging Medical Technologies (EMT) Summit – Oct. 19-21, 2015
    • Other Past Conferences
  • Online Store
  • Contact Us
  • Sign In

Issue: Vol. 5, No. 14 - October 17, 2018

Go Back to Medtech Strategist Issue Archive

Table of Contents – MedTech Strategist, Vol. 5, No. 14, October 17, 2018 (44 Pages):

 

“From the Community Blog,” by the MedTech Strategist Team

“MD Start: Building Medtech Companies in Europe,” by David Cassak

“Regulatory Shifts for HCT/P Products Put Orthobiologics Manufacturers on the Spot,” by Wendy Diller

Sidebars:

   – “FDA’s Evolving Criteria for Tissue-based Biologics: Takeaways,” by Wendy DIller

   – “MiMedx Wins an Orthopedic Rarity: RMAT Designation for AmnioFix Injectable,” by Wendy Diller

“Three Strategies to Avoid Medical Device Commoditization,” by Tom Dudnyk, VIVO Agency

Start-Ups to Watch—”EmboMedics: Thinking Organically about Embolization,” by Colin Miller

Start-Ups to Watch—”Kobara Medical: Epicardial Pacing Provides Advantages for Heart Failure Patients,” by Mary Stuart


Articles in This Issue

Start-Ups to Watch—”Kobara Medical: Epicardial Pacing Provides Advantages for Heart Failure Patients,” by Mary Stuart

Article Categories:

Cardiovascular/Vascular · Start-Ups to Watch

Start-Ups to Watch—”EmboMedics: Thinking Organically about Embolization,” by Colin Miller

Article Categories:

Biopharma/Biomaterials · Oncology · Start-Ups to Watch

“Three Strategies to Avoid Medical Device Commoditization,” by Tom Dudnyk, VIVO Agency

Article Categories:

Business Strategies · Perspective & Commentary

“Regulatory Shifts for HCT/P Products Put Orthobiologics Manufacturers on the Spot,” by Wendy Diller

Article Categories:

Orthopedics/Spine · Regenerative Medicine/Cell Therapy · Regulatory & Reimbursement

“MD Start: Building Medtech Companies in Europe,” by David Cassak

Article Categories:

Investors & Dealmaking

Innovation In Medtech, LLC © © 2014–2019 All Rights Reserved.
  • Home
  • Contact
  • #0 (no title)
  • #0 (no title)

Copyright © 2019 · Steve Levin Theme on Genesis Framework · WordPress · Log in